Advisory Alpha’s Immunomedics Inc IMMU Stock Holding History

Advisory Alpha’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40	Closed	-$3K	–	728
2020 Q3	$3K	Buy	+40	New	+$2.02K	﹤0.01%	596
2020 Q2	–	Sell	-40	Closed	-$1.05K	–	689
2020 Q1	$1.05K	Hold	40	–	–	﹤0.01%	640
2019 Q4	$772	Hold	40	–	–	﹤0.01%	701
2019 Q3	$550	Buy	+40	New	+$588	﹤0.01%	800
2019 Q2	–	Sell	-40	Closed	-$573	–	717
2019 Q1	$573	Buy	+40	New	+$645	﹤0.01%	647

Advisory Alpha's IMMU Position: Q4 2020 in Review

Advisory Alpha sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 40 shares — an estimated $3K sold.

Advisory Alpha first reported a position in IMMU in Q1 2019 and held it in 5 quarters. The position peaked at $3K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Advisory Alpha reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 40 Immunomedics Inc shares in Q4 2020, an estimated $3K.
Advisory Alpha first reported a position in Immunomedics Inc in Q1 2019 and held it in 5 quarters.
Advisory Alpha's Immunomedics Inc position peaked at $3K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.